Bristol Myers buys Mirati Therapeutics09.10.2023 at 09:49Vladimir PetenyovNews editorpress@blackterminal.comBristol Myers is buying Mirati Therapeutics for $5.8 billion, or $58 per share. Deal is expected to close in the first half of 2024.Mirati TherapeuticsMRTX58.7 USD+0.00%ReviewSource: news.bms.com
